Clinical Trial

A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this clinical trial is to assess the efficacy and safety of HTMC0658 tablets in treating subjects with chronic rhinosinusitis without nasal polyps (CRSsNP).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-12.
Trial Details
NCT Number NCT07174115
Lead Sponsor Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Conditions Chronic Sinusitis Without Nasal Polyps
Enrollment 30 participants
Start Date 2025-08-18
Primary Completion 2026-04 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-19